How Much Blockage Requires A Stent? | Numbers Vs Symptoms

Hearing “70% blocked” can feel final. In real care, a stent decision is rarely based on one number. A stent (placed during PCI) is meant to restore blood flow when a narrowing is causing angina, showing low flow during exertion on testing, or driving urgent care like a heart attack.

This guide explains what “blockage” measures, why the same percent can lead to different plans, and which tests tend to settle the question.

How Blockage Is Measured In The First Place

“Blockage” usually means stenosis: narrowing inside a coronary artery from plaque. The percent you’re told is most often estimated during a coronary angiogram, an X-ray study done in the cath lab.

An angiogram outlines the inside channel of the artery after contrast dye is injected. The reader compares the narrow spot with a nearby segment that looks more open and reports a percent. That estimate helps, yet it is not a direct measure of blood supply.

Percent Narrowing Is Not The Same As Low Blood Flow

Resting flow can be fine even when the artery is narrowed. Trouble shows up when the heart needs more oxygen, like climbing stairs. That’s why symptoms and “does this cause ischemia?” testing matter as much as the percent.

Location Changes What A Number Means

A mid-sized narrowing in a small branch can matter less than a smaller-looking narrowing in the left main coronary artery, which feeds a large share of the heart. The same percent can carry different risk based on territory and vessel size.

Measurements That Help Decide On Stenting

Most decisions combine anatomy with a second layer: evidence that the narrowing is limiting blood flow. You might see one or more of these tools:

• Stress testing (treadmill or medicine-based) to check for ischemia during exertion.
• FFR or iFR in the cath lab, using a pressure wire across the lesion.
• IVUS or OCT imaging inside the artery to size the vessel and judge plaque shape.

FFR and iFR are often used when the angiogram shows an “intermediate” narrowing. In the 2021 revascularization guidance slide set, stable patients with intermediate stenoses and FFR > 0.80 or iFR > 0.89 are generally not treated with PCI in that setting.

What FFR And iFR Mean Without The Jargon

These numbers compare pressure before and after the narrowing. A larger pressure drop suggests the lesion is restricting flow during activity. When the value is above the usual cutoff in a stable patient, the lesion is often left alone and treated with medicines.

How Much Blockage Requires A Stent? What Doctors Measure

If you’re hunting for the number people quote most, it’s 70%. A stenosis at or above that level in a major coronary artery is more likely to be treated with PCI when symptoms or testing point to low flow. Cath lab reports often label 70%+ as “severe.”

Still, “severe” on paper does not force a stent. Patient resources describe angioplasty and stenting as a way to widen a narrowed coronary artery when that narrowing is causing trouble. The NHS overview of coronary angioplasty defines the procedure, and the Mayo Clinic overview of coronary angioplasty and stents explains how PCI raises blood flow but does not remove the causes of plaque buildup.

So the practical question becomes: is this narrowing linked to symptoms or ischemia, and will opening it change what you feel or what your risk looks like?

Blockage Level For A Stent In Coronary Arteries

Clinicians often group stenosis into ranges. These ranges are not rules. They’re shorthand that helps decide what to do next: medicines, more testing, PCI, or sometimes bypass surgery.

Use the table below as a translation guide for how percent findings often read, and what the next step tends to be once symptoms and test results are added in.

Angiogram Range	Typical Meaning	Common Next Step
< 30%	Mild plaque without a tight pinch	Risk-factor treatment; search for other causes of symptoms
30–49%	Visible narrowing, often not flow-limiting by itself	Medicines; stress test if symptoms fit
50–59%	Borderline lesion where the picture can mislead	Functional testing or FFR/iFR
60–69%	Intermediate stenosis where physiology often decides	FFR/iFR or imaging in the cath lab
≥ 70% (major vessel)	Often labeled severe	PCI often weighed if angina or ischemia is present
Left main (often ≥ 50%)	Large territory at stake	More imaging and heart-team review; PCI or bypass based on anatomy
100% occlusion	Artery fully blocked; collateral flow may exist	Urgent PCI in heart attack; elective CTO PCI in selected cases
Multiple tight lesions	Diffuse disease across many spots	PCI to culprit lesions or bypass based on overall pattern

When Medicines Come Before A Stent

In stable coronary disease, many people get solid relief from medicines alone. That can include anti-anginal drugs, cholesterol-lowering therapy, blood pressure control, and stopping smoking. If chest pain settles and testing does not show a high ischemic burden, PCI may not add much for long-term outcomes, even when a narrowing looks large.

This is where physiology testing earns its keep. A 60% lesion with an FFR above the cutoff often behaves like a bystander lesion. Stenting that spot can add procedure risk without a clear payoff.

What “Stable” Means Here

Stable means symptoms are predictable and not worsening fast, with no clear signs of ongoing heart muscle injury. New or worsening chest pain at rest, rising troponin, or ECG changes can shift care toward urgent catheterization.

When A Stent Is More Likely To Help

Stents are used most often in these settings:

• Heart attack care, where opening the culprit artery fast can save heart muscle.
• Unstable angina or NSTEMI, where a tight lesion plus symptoms can lead to urgent PCI.
• Stable angina that persists after medicines, with proof that a lesion is causing ischemia on testing or physiology.

Guidelines for chronic coronary syndromes also emphasize linking anatomy with ischemia and symptoms when thinking about revascularization. See the current hub on the ESC chronic coronary syndromes guideline page.

Left Main And Proximal LAD Lesions

Blockages in the left main artery or the early part of the LAD carry extra weight since they feed a large area of myocardium. Decisions here often involve interventional cardiology and cardiac surgery reviewing imaging together, then matching the plan to anatomy and patient risk.

Why Two People With The Same Percent Get Different Plans

Two patients can both have a “70%” lesion and hear different recommendations. A few common reasons:

• Symptoms differ. One person has exertional chest pressure; the other has none.
• Ischemia differs. One has stress testing that matches the lesion territory; the other has a low-risk result.
• Lesion shape differs. A long, calcified narrowing behaves differently from a short, smooth plaque.
• Risk differs. Kidney disease, bleeding history, and frailty can shift the risk-benefit balance.

This is also why many cath reports pair percent stenosis with notes like “matches symptoms,” and why pressure-wire testing is used so often in intermediate disease.

Stent Tradeoffs To Know Before You Agree

A stent can relieve angina quickly when the lesion is truly flow-limiting, and it can be lifesaving during an acute heart attack. It also comes with tradeoffs that should be on the table before the procedure.

Blood Thinners And Bleeding

After PCI, most people take dual antiplatelet therapy (DAPT) for a period of time to lower clot risk inside the stent. That raises bleeding risk. Upcoming surgery, dental work, falls risk, and prior bleeding history matter when choosing timing and drug duration.

Re-Narrowing And New Plaque

Drug-eluting stents lowered re-narrowing compared with older stents, yet restenosis can still happen. Also, plaque can grow in other segments over time. A stent treats one segment; it does not remove plaque-building drivers.

Table: Signals That Push Toward PCI Or Away From It

This table shows findings that often steer a plan toward stenting and findings that often back deferring PCI in stable disease.

Signal	Often Pushes Toward PCI	Often Backs Deferring PCI
Symptoms	Angina with modest exertion after meds	No angina, atypical symptoms, symptoms resolved on meds
Stress testing	Ischemia in the matching territory	No ischemia, low-risk pattern
FFR / iFR	FFR ≤ 0.80 or iFR below lab cutoff	FFR > 0.80 or iFR > 0.89 in a stable patient
Lesion site	Left main, proximal LAD, large territory	Small branch or limited territory
Clinical setting	STEMI, NSTEMI, unstable angina	Stable symptoms, no injury markers
Medicine response	Symptoms persist on a good regimen	Symptoms settle with medicines

Questions To Ask At Your Next Visit

These questions keep the talk concrete:

• Which artery is narrowed, and how much heart muscle does it feed?
• Is my lesion intermediate or clearly severe on imaging?
• Do we have stress test or FFR/iFR data that links this lesion to my symptoms?
• What medicine plan are we using, and when do we reassess?
• If I get a stent, how long will I need DAPT, and what does that mean for procedures I may need?

A Practical Checklist For Stent Decisions

• Match the number to symptoms. A percent alone is not a diagnosis.
• Ask for the ischemia link. Stress testing or FFR/iFR should back up the plan in stable disease.
• Clarify the goal. Symptom relief, urgent heart attack care, or both.
• Talk through DAPT timing. Bleeding history and upcoming procedures matter.
• Get the full map. One stent may not solve diffuse disease.